HKPD · Cellyan Biotechnology Co Ltd
United States · RS rating 7 · As of 2026-11-03
| Price | 1.94 USD |
|---|---|
| 1-day change | +6.0% |
| RS rating (overall / 1M / 3M / 12M) | 7 / 41 / 3 / 4 |
| Stage | Declining |
| Composite / Minervini / CANSLIM score | 21 / 6 / 13 |
| Industry group (rank) | Medical-Biomed/Biotech (154) |
| EPS growth Q/Q | – |
| Sales growth Q/Q | – |
| Distance from 52-week high | +92.3% |
| Market cap (USD) | $14.6M |